Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus who were, or were not, on antihyperglycaemic agents at screening

被引：0
|
作者：
Gonzalez-Galvez, G. [1 ]
Jodar, E. [2 ]
Kim, K. [3 ]
Alba, M. [4 ]
Tong, C. [4 ]
Meininger, G. [4 ]
机构：
[1] Inst Jalisciense Invest Diabet & Obesidad, Guadalajara, Jalisco, Mexico
[2] Hosp Quiron, Dept Endocrinol, Madrid, Spain
[3] Dongguk Univ, Sch Med, Ilsan Hosp, Dept Internal Med, Goyang, South Korea
[4] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
853
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of hydroxychloroquine as add-on therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs
    Chakravarti, H. N.
    Nag, A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (03) : 481 - 492
  • [42] Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes
    Qiu, Rong
    Balis, Dainius
    Capuano, George
    Xie, John
    Meininger, Gary
    [J]. DIABETES THERAPY, 2016, 7 (04) : 659 - 678
  • [43] Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes
    Rong Qiu
    Dainius Balis
    George Capuano
    John Xie
    Gary Meininger
    [J]. Diabetes Therapy, 2016, 7 : 659 - 678
  • [44] Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
    Sinclair, Alan
    Bode, Bruce
    Harris, Stewart
    Vijapurkar, Ujjwala
    Mayer, Cristiana
    Fung, Albert
    Shaw, Wayne
    Usiskin, Keith
    Desai, Mehul
    Meininger, Gary
    [J]. BMC ENDOCRINE DISORDERS, 2014, 14
  • [45] Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
    Alan Sinclair
    Bruce Bode
    Stewart Harris
    Ujjwala Vijapurkar
    Cristiana Mayer
    Albert Fung
    Wayne Shaw
    Keith Usiskin
    Mehul Desai
    Gary Meininger
    [J]. BMC Endocrine Disorders, 14
  • [46] Long-term efficacy and safety of canagliflozin in older patients with type 2 diabetes mellitus over 104 weeks
    Stenlof, K.
    Bode, B.
    Harris, S.
    Sullivan, D.
    Fung, A.
    Usiskin, K.
    [J]. DIABETOLOGIA, 2014, 57 : S8 - S9
  • [47] Efficacy and Tolerability of Pioglitazone in Patients with Type 2 Diabetes MellitusComparison with Other Oral Antihyperglycaemic Agents
    Giuseppe Derosa
    [J]. Drugs, 2010, 70 : 1945 - 1961
  • [48] Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis
    Sinclair, Alan J.
    Bode, Bruce
    Harris, Stewart
    Vijapurkar, Ujjwala
    Shaw, Wayne
    Desai, Mehul
    Meininger, Gary
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (03) : 543 - 552
  • [49] Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy
    Riedel, Aylin A.
    Heien, Herbert
    Wogen, Jenifer
    Plauschinat, Craig A.
    [J]. PHARMACOTHERAPY, 2007, 27 (08): : 1102 - 1110
  • [50] Cardiovascular disease and risk factor profiles of patients with type 2 diabetes mellitus who were eligible for but did not receive a statin
    Tunceli, K.
    Sun, P.
    Zhang, Q.
    Ambegaonkar, B.
    Lento, K.
    Davies, M. J.
    Seck, T.
    Radican, L.
    [J]. DIABETOLOGIA, 2011, 54 : S506 - S506
12345